Nalaganje...
Efficacy and Tolerability of Combination Therapy with Interferon-Alfa Plus Ribavirin in Patients with Chronic Hepatitis C Virus Infection: A Single-Center Study in Relapsers and Nonresponders to Previous Treatment with High-Dose Interferon-Alfa Monotherapy
Background: In chronic hepatitis C virus (HCV) infection, interferon (IFN) monotherapy usually is carried out at doses of 3 to 6 million units (MU) 3 times per week, but treatment efficacy is low. Objective: The aim of our study was to assess the efficacy and tolerability of IFN-alfa(2b) in combinat...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2003
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053042/ https://ncbi.nlm.nih.gov/pubmed/24944362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0011-393X(03)00024-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|